Clinical trials data
Verbal Fluency in pain and fatigue trials: 53 registered studies
Every registered pain and fatigue study on ClinicalTrials.gov that names Verbal Fluency in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered pain and fatigue studies name it in an outcome measure
- 53
- Name it in a primary outcome, 32%
- 17 of 53
Tests named in the same studies
- 1
Digit Span Test19 studies, 11 as a primary outcome
- 2
Trail Making Test18 studies, 7 as a primary outcome
- 3
Verbal Learning16 studies, 5 as a primary outcome
- 4
Stroop Color-Word Test13 studies, 4 as a primary outcome
- 5
Category Fluency11 studies, 4 as a primary outcome
- 6
Symbol Coding10 studies, 3 as a primary outcome
- 7
Paced Visual Serial Addition Test7 studies, 3 as a primary outcome
- 8
Tower Planning4 studies, 3 as a primary outcome
- 9
Matrix Reasoning4 studies, 2 as a primary outcome
- 10
Psychomotor Vigilance Task3 studies, 2 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 3 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 2 | 1 |
| 2012 | 2 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 3 | 2 |
| 2016 | 3 | 1 |
| 2017 | 3 | 1 |
| 2018 | 0 | 0 |
| 2019 | 3 | 1 |
| 2020 | 4 | 3 |
| 2021 | 3 | 0 |
| 2022 | 1 | 0 |
| 2023 | 8 | 2 |
| 2024 | 4 | 0 |
| 2025 | 6 | 2 |
| 2026 | 5 | 1 |
Phases and study sizes
By phase
- Phase 1/21 studies, 0 as a primary outcome
- Phase 29 studies, 3 as a primary outcome
- Phase 2/31 studies, 0 as a primary outcome
- Phase 34 studies, 2 as a primary outcome
- Phase 41 studies, 1 as a primary outcome
- Not applicable29 studies, 7 as a primary outcome
- Observational8 studies, 4 as a primary outcome
Participants per study
- Not applicable70 median, 39 to 151
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Not applicable | 28 | 70 | 39 to 151 |
When pain and fatigue trials measure it
Latest time point of each outcome
- Within a day4 outcomes, 1 as a primary outcome
- Up to 4 weeks9 outcomes, 3 as a primary outcome
- 1 to 3 months18 outcomes, 6 as a primary outcome
- 3 to 6 months8 outcomes, 2 as a primary outcome
- 6 to 12 months4 outcomes, 2 as a primary outcome
- 1 to 2 years4 outcomes, 2 as a primary outcome
- No duration given6 outcomes, 1 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
47 of the 53 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting8 studies, 2 as a primary outcome
- Not yet recruiting3 studies, 1 as a primary outcome
- Active, not recruiting2 studies, 1 as a primary outcome
- Completed28 studies, 7 as a primary outcome
- Stopped early3 studies, 3 as a primary outcome
- Status unknown9 studies, 3 as a primary outcome
What they test
- Behavioral8 studies, 4 as a primary outcome
- Drug15 studies, 6 as a primary outcome
- Device12 studies, 5 as a primary outcome
- Dietary supplement3 studies, 0 as a primary outcome
- Procedure4 studies, 0 as a primary outcome
- Diagnostic test1 studies, 1 as a primary outcome
- Biological2 studies, 0 as a primary outcome
- Radiation3 studies, 1 as a primary outcome
- Other13 studies, 2 as a primary outcome
- None given2 studies, 1 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States24 studies, 8 as a primary outcome
- Italy4 studies, 1 as a primary outcome
- Türkiye4 studies, 1 as a primary outcome
- Brazil3 studies, 1 as a primary outcome
- France3 studies, 0 as a primary outcome
- Germany3 studies, 0 as a primary outcome
- Canada2 studies, 0 as a primary outcome
- Denmark2 studies, 1 as a primary outcome
- Greece2 studies, 0 as a primary outcome
- Hungary2 studies, 0 as a primary outcome
- Netherlands2 studies, 1 as a primary outcome
- Spain2 studies, 1 as a primary outcome
27 countries in all. A study with sites in several counts in each; 2 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed pain and fatigue studies that name Verbal Fluency: 16 of 28, 57%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed pain and fatigue studies that name Verbal Fluency | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 6, 21% | 776, 10% |
| Results on ClinicalTrials.gov only | 3, 11% | 1,139, 14% |
| A results paper only | 7, 25% | 1,711, 22% |
| Neither | 12, 43% | 4,327, 54% |
The 53 studies
53 studies match. 17 name Verbal Fluency in a primary outcome. Median size 80 participants. Median time to the primary outcome: 10 weeks.
Loading 53 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 3 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 2 | 1 |
| 2012 | 2 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 3 | 2 |
| 2016 | 3 | 1 |
| 2017 | 3 | 1 |
| 2018 | 0 | 0 |
| 2019 | 3 | 1 |
| 2020 | 4 | 3 |
| 2021 | 3 | 0 |
| 2022 | 1 | 0 |
| 2023 | 8 | 2 |
| 2024 | 4 | 0 |
| 2025 | 6 | 2 |
| 2026 | 5 | 1 |
Library tests named most
Conditions
Phases
Participants
Lead sponsor: industry 2, other 51. Interventional 45, observational 8.
As a primary outcomeSecondary or other outcomeVerbal Fluency
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07842302 | Start2026 | PhaseNot applicable | ConditionsMultiple sclerosis, Pain and fatigue | Participants80 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07766980 | Start2026 | PhasePhase 2 | ConditionsPain and fatigue | Participants20 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07709234 | Start2026 | PhaseNot applicable | ConditionsCOVID-19 and long COVID, Pain and fatigue | Participants20 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07539116 | Start2024 | PhaseNot applicable | ConditionsPain and fatigue | Participants183 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07393672 | Start2026 | PhasePhase 2 | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants104 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07357688 | Start2026 | PhaseNot applicable | ConditionsPain and fatigue | Participants99 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07304843 | Start2023 | PhasePhase 1/2 | ConditionsPain and fatigue | Participants207 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT07273604 | Start2015 | PhaseNot applicable | ConditionsMultiple sclerosis, Depression and bipolar disorder, Anxiety, PTSD and OCD, Pain and fatigue | Participants148 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06922409 | Start2025 | PhaseNot applicable | ConditionsStroke, Depression and bipolar disorder, Sleep and sleep disorders, Pain and fatigue | Participants45 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06871852 | Start2025 | PhaseNot applicable | ConditionsAging, frailty and exercise, Pain and fatigue | Participants54 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06831916 | Start2025 | PhasePhase 2 | ConditionsAnxiety, PTSD and OCD, Pain and fatigue | Participants104 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06808048 | Start2025 | PhaseNot applicable | ConditionsSubstance use and addiction, Pain and fatigue | Participants180 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06586398 | Start2025 | PhaseNot applicable | ConditionsCOVID-19 and long COVID, Pain and fatigue | Participants10 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06511674 | Start2024 | PhaseNot applicable | ConditionsCancer, Pain and fatigue | Participants625 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06476496 | Start2024 | PhaseNot applicable | ConditionsCOVID-19 and long COVID, Pain and fatigue | Participants93 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06448923 | Start2025 | PhasePhase 2 | ConditionsPain and fatigue | Participants225 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT06352099 | Start2024 | PhaseNot applicable | ConditionsAging, frailty and exercise, Pain and fatigue | Participants36 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT06074848 | Start2023 | PhasePhase 2 | ConditionsDepression and bipolar disorder, COVID-19 and long COVID, Pain and fatigue | Participants48 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT06032715 | Start2023 | PhaseNot applicable | ConditionsSleep and sleep disorders, Pain and fatigue | Participants120 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT05926986 | Start2023 | PhaseNot applicable | ConditionsPain and fatigue | Participants30 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05748483 | Start2023 | PhasePhase 3 | ConditionsPain and fatigue | Participants545 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT05625776 | Start2023 | PhaseNot applicable | ConditionsPain and fatigue | Participants23 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05624814 | Start2023 | PhaseObservational | ConditionsPain and fatigue | Participants60 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
| NCT05356988 | Start2022 | PhaseNot applicable | ConditionsDepression and bipolar disorder, Cancer, Aging, frailty and exercise, Sleep and sleep disorders, Anxiety, PTSD and OCD, Pain and fatigue | Participants415 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT05321693 | Start2021 | PhasePhase 2 | ConditionsPain and fatigue | Participants70 | Lead sponsorOther | StatusStatus unknown | Library tests named
|
Questions, answered from the data
How many pain and fatigue trials use Verbal Fluency?
53 registered pain and fatigue studies on ClinicalTrials.gov name it in an outcome measure, 17 of them in a primary outcome: 8% of the condition's 681 studies with a cognitive outcome, against 11% of all of them. It is the 6th most named test in pain and fatigue trials.
Which tests do pain and fatigue trials use with Verbal Fluency?
The Digit Span Test (19 studies), the Trail Making Test (18 studies) and Verbal Learning (16 studies).
When do pain and fatigue trials measure Verbal Fluency?
Half of the primary outcomes that name Verbal Fluency are measured within 10 weeks of the start, and the middle half from 6 weeks to 7 months. 16 primary outcomes give a duration.
How many completed pain and fatigue trials that use Verbal Fluency have reported results?
16 of the 28 completed studies that name it, 57%, have reported results: 9 posted them on ClinicalTrials.gov, 13 have a results paper linked to the registry record, and 6 did both. The other 12 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run Verbal Fluency in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.